Research Summary
Rivaroxaban is an anticoagulant medication belonging to the class of direct oral anticoagulants (DOACs). It is commonly prescribed to reduce the risk of blood clots in various medical conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Rivaroxaban works by inhibiting Factor Xa, a key component in the blood clotting cascade. Unlike traditional anticoagulants, it does not require routine monitoring of blood levels, offering more convenient management for patients. Rivaroxaban has gained widespread use for its effectiveness in preventing thromboembolic events and its oral administration, making it a valuable option in the prevention and treatment of conditions associated with abnormal blood clot formation. However, its use should be carefully monitored, and dosage adjustments may be necessary based on individual patient factors and medical conditions.
According to DIResearch's in-depth investigation and research, the global Rivaroxaban market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Rivaroxaban include Bayer, Johnson & Johnson etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Rivaroxaban. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Rivaroxaban market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Rivaroxaban market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Rivaroxaban industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Rivaroxaban Include:
Bayer
Johnson & Johnson
Rivaroxaban Product Segment Include:
2.5 mg
10 mg
15 mg
20 mg
Rivaroxaban Product Application Include:
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Rivaroxaban Industry PESTEL Analysis
Chapter 3: Global Rivaroxaban Industry Porter's Five Forces Analysis
Chapter 4: Global Rivaroxaban Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Rivaroxaban Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Rivaroxaban Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Rivaroxaban Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Rivaroxaban Market Overview 1.1 Product Definition and Statistical Scope 1.2 Rivaroxaban Product by Type 1.2.1 Global Rivaroxaban Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 2.5 mg 1.2.3 10 mg 1.2.4 15 mg 1.2.5 20 mg 1.3 Rivaroxaban Product by Application 1.3.1 Global Rivaroxaban Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Acute Coronary Syndrome (ACS) 1.3.3 Venous Thromboembolism (VTE) 1.4 Global Rivaroxaban Market Revenue and Sales Analysis 1.4.1 Global Rivaroxaban Market Size Analysis (2019-2030) 1.4.2 Global Rivaroxaban Market Sales Analysis (2019-2030) 1.4.3 Global Rivaroxaban Market Sales Price Trend Analysis (2019-2030) 1.5 Rivaroxaban Market Development Status and Trends 1.5.1 Rivaroxaban Industry Development Status Analysis 1.5.2 Rivaroxaban Industry Development Trends Analysis 2 Rivaroxaban Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Rivaroxaban Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Rivaroxaban Market Analysis by Regions 4.1 Rivaroxaban Overall Market: 2023 VS 2024 VS 2030 4.2 Global Rivaroxaban Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Rivaroxaban Revenue and Market Share by Region (2019-2024) 4.2.2 Global Rivaroxaban Revenue Forecast by Region (2025-2030) 4.3 Global Rivaroxaban Sales and Forecast Analysis (2019-2030) 4.3.1 Global Rivaroxaban Sales and Market Share by Region (2019-2024) 4.3.2 Global Rivaroxaban Sales Forecast by Region (2025-2030) 4.4 Global Rivaroxaban Sales Price Trend Analysis (2019-2030) 5 Global Rivaroxaban Market Size by Type and Application 5.1 Global Rivaroxaban Market Size by Type 5.1.1 Global Rivaroxaban Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Rivaroxaban Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Rivaroxaban Market Size by Application 5.2.1 Global Rivaroxaban Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Rivaroxaban Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Rivaroxaban Market Size by Type 6.3.1 North America Rivaroxaban Sales by Type (2019-2030) 6.3.2 North America Rivaroxaban Revenue by Type (2019-2030) 6.4 North America Rivaroxaban Market Size by Application 6.4.1 North America Rivaroxaban Sales by Application (2019-2030) 6.4.2 North America Rivaroxaban Revenue by Application (2019-2030) 6.5 North America Rivaroxaban Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Rivaroxaban Market Size by Type 7.3.1 Europe Rivaroxaban Sales by Type (2019-2030) 7.3.2 Europe Rivaroxaban Revenue by Type (2019-2030) 7.4 Europe Rivaroxaban Market Size by Application 7.4.1 Europe Rivaroxaban Sales by Application (2019-2030) 7.4.2 ? Europe Rivaroxaban Revenue by Application (2019-2030) 7.5 Europe Rivaroxaban Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Rivaroxaban Market Size by Type 8.3.1 China Rivaroxaban Sales by Type (2019-2030) 8.3.2 China Rivaroxaban Revenue by Type (2019-2030) 8.4 China Rivaroxaban Market Size by Application 8.4.1 China Rivaroxaban Sales by Application (2019-2030) 8.4.2 China Rivaroxaban Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Rivaroxaban Market Size by Type 9.3.1 APAC (excl. China) Rivaroxaban Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Rivaroxaban Revenue by Type (2019-2030) 9.4 APAC (excl. China) Rivaroxaban Market Size by Application 9.4.1 APAC (excl. China) Rivaroxaban Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Rivaroxaban Revenue by Application (2019-2030) 9.5 APAC (excl. China) Rivaroxaban Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Rivaroxaban Market Size by Type 10.3.1 Latin America Rivaroxaban Sales by Type (2019-2030) 10.3.2 Latin America Rivaroxaban Revenue by Type (2019-2030) 10.4 Latin America Rivaroxaban Market Size by Application 10.4.1 Latin America Rivaroxaban Sales by Application (2019-2030) 10.4.2 Latin America Rivaroxaban Revenue by Application (2019-2030) 10.5 Latin America Rivaroxaban Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Rivaroxaban Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Rivaroxaban Market Size by Type 11.3.1 Middle East & Africa Rivaroxaban Sales by Type (2019-2030) 11.3.2 Middle East & Africa Rivaroxaban Revenue by Type (2019-2030) 11.4 Middle East & Africa Rivaroxaban Market Size by Application 11.4.1 Middle East & Africa Rivaroxaban Sales by Application (2019-2030) 11.4.2 Middle East & Africa Rivaroxaban Revenue by Application (2019-2030) 11.5 Middle East & Africa Rivaroxaban Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Rivaroxaban Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Rivaroxaban Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Rivaroxaban Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Rivaroxaban Average Sales Price by Manufacturers (2020-2024) 12.2 Rivaroxaban Competitive Landscape Analysis and Market Dynamic 12.2.1 Rivaroxaban Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Bayer 13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Bayer Rivaroxaban Product Portfolio 13.1.3 Bayer Rivaroxaban Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Johnson & Johnson 13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Johnson & Johnson Rivaroxaban Product Portfolio 13.2.3 Johnson & Johnson Rivaroxaban Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Rivaroxaban Industry Chain Analysis 14.2 Rivaroxaban Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Rivaroxaban Typical Downstream Customers 14.4 Rivaroxaban Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support